Effect of antioxidant treatment in global ischemia and ischemic postconditioning in the rat hippocampus.
Ischemic postconditioning is a very effective way how to prevent delayed neuronal death. Effect of Ginkgo biloba extract (EGb 761; 40 mg/kg) posttreatment was studied on the rat model of transient forebrain ischemia and ischemia/postconditioning. Global ischemia was produced by four-vessel occlusion in Wistar male rats. Two experimental protocols were used: (a) 10 min of ischemia/7 days of reperfusion with or without EGb 761 treatment or (b) 10 min of ischemia/2 days of reperfusion/5 min of ischemia (postconditioning), following 5 days of reperfusion. EGb 761 was applied as follows: 30 min before 10 min of ischemia then 5 h, 1 and 2 days after 10 min of ischemia. Fluoro Jade B, marker for neuronal degeneration, was used for quantitative analysis of the most vulnerable hippocampal CA1 neurons. Cognitive and memory functions were tested by Morris water maze, as well. Administration of EGb 761 30 min before 10 min of ischemia or 5 h after ischemia has rather no protective effect on neuronal survival in CA1 region. Ten minutes of ischemia following ischemic postconditioning after 2 days of reperfusion trigger a significant neuroprotection of CA1 neurons, but it is abolished by EGb 761 posttreatment. Ischemia/postconditioning group showed a significant improvement of learning and memory on the seventh day of reperfusion. Protection of the most vulnerable CA1 neurons after ischemia/postconditioning is abolished by exogenous antioxidant treatment used in different time intervals after initial ischemia. Moreover, combination of EGb 761 administration with repeated stress (5 min ischemia used as postconditioning) causes cumulative injury of CA1 neurons.
Domoráková
Iveta
I
Department of Histology and Embryology, Faculty of Medicine, PJ Safárik University, 040 01 Kosice, Slovak Republic. iveta.domorakova@gmail.com
Mechírová
Eva
E
Danková
Marianna
M
Danielisová
Viera
V
Burda
Jozef
J
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D016923:Cell Death / Q000187:drug effects; D005452:Fluoresceins; D020441:Ginkgo biloba; D006624:Hippocampus / Q000187:drug effects / Q000473:pathology*; D002546:Ischemic Attack, Transient / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D018782:Maze Learning; D009410:Nerve Degeneration / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology*; D009474:Neurons / Q000187:drug effects; D018696:Neuroprotective Agents / Q000494:pharmacology; D009930:Organic Chemicals; D010936:Plant Extracts / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D000096983:Ginkgo Extract
D000975:Antioxidants; D005452:Fluoresceins; D018696:Neuroprotective Agents; D009930:Organic Chemicals; D010936:Plant Extracts; C435731:fluoro jade; C063170:Ginkgo biloba extract; D000096983:Ginkgo Extract